Literature DB >> 35747862

SERUM ZONULIN LEVELS IN HYPOTHYROID AND EUTHYROID PATIENTS WITH HASHIMOTO'S THYROIDITIS - A PILOT STUDY.

D G Tomov1, B A Levterova2, V N Mihaylova3, D M Troev4, M Z Miteva4, M M Orbetzova4.   

Abstract

Context: Human zonulin is a protein that regulates the intercellular tight junctions in various tissues and organs of the human body. Hashimoto's thyroiditis (HT) is one of the most common endocrine autoimmune disorder, but the role of increased intestinal permeability in its pathogenesis is still being studied. Objective and design: This pilot cross-sectional study investigates serum zonulin concentration in adults with Hashimoto's thyroiditis and assesses the relationship between zonulin levels, clinical hormonal and immunological characteristics. Subjects and methods: A group of 62 adults with HT participated in this study and were divided into three groups: hypothyroid (n=33) euthyroid (n=25) and hyperthyroid (n=4). Serum zonulin was determined using an ELISA method.
Results: Age, gender and BMI were different between groups (hypothyroid and euthyroid ones). Serum zonulin values ranged from 2.6 to 198.0 ng/mL in participants. A direct positive correlation was found between serum zonulin levels and weight and BMI (r = 0.351, p = 0.008 and r = 0.236, p = 0.05, respectively). Conclusions: There is no correlation between zonulin and thyroid hormones or autoantibodies in Hashimoto thyroiditis patients. There is a difference in zonulin levels between the studied groups, but they are not statistically significant. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Hashimoto’s thyroiditis (HT); increased intestinal permeability (IIP); zonulin

Year:  2021        PMID: 35747862      PMCID: PMC9206160          DOI: 10.4183/aeb.2021.449

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  28 in total

Review 1.  Immunity, inflammation, and allergy in the gut.

Authors:  Thomas T Macdonald; Giovanni Monteleone
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 2.  Alterations in intestinal permeability.

Authors:  M C Arrieta; L Bistritz; J B Meddings
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 3.  Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.

Authors:  Alessio Fasano; Terez Shea-Donohue
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-09

Review 4.  Autoimmune thyroid disorders.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Alda Corrado; Andrea Di Domenicantonio; Poupak Fallahi
Journal:  Autoimmun Rev       Date:  2014-10-25       Impact factor: 9.754

Review 5.  Does microbiota composition affect thyroid homeostasis?

Authors:  Camilla Virili; Marco Centanni
Journal:  Endocrine       Date:  2014-12-17       Impact factor: 3.633

Review 6.  Hashimoto thyroiditis: clinical and diagnostic criteria.

Authors:  P Caturegli; A De Remigis; N R Rose
Journal:  Autoimmun Rev       Date:  2014-01-13       Impact factor: 9.754

Review 7.  Gut microbiota and Hashimoto's thyroiditis.

Authors:  Camilla Virili; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga; Marco Centanni
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

8.  Human zonulin, a potential modulator of intestinal tight junctions.

Authors:  W Wang; S Uzzau; S E Goldblum; A Fasano
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

9.  Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations.

Authors:  Bodil Ohlsson; Marju Orho-Melander; Peter M Nilsson
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

10.  Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study.

Authors:  Martin Aasbrenn; Stian Lydersen; Per G Farup
Journal:  BMC Endocr Disord       Date:  2020-07-22       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.